We offer cutting edge technology that provides our customers an advantage when developing new pharmaceuticals.
Our third generation biosensors’ technology is unique and patented.
It reduces animal testing and makes the drug development process more efficient and cost effective.
Attana to present scientific results at a conference for antibodies in clinical oncology on Cyprus. Welcome to listen or contact us for more information.
Attana are presenting recent discoveries of nanoparticles for therapeutic applications at the 11th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine in Basel. Welcome to listen or contact us for more information.